We are live on ! Find out more
ALBO

Albireo Pharma Inc

Delisted

ALBO was delisted on the 2nd of March, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
BC
1
Broadfin Capital
New York
$2.87M
Wellington Management Group
2
Wellington Management Group
Massachusetts
$2.34M +$762K +10,962 +44%
William Blair & Company
3
William Blair & Company
Illinois
$1.88M -$1.07M -15,420 -38%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.07M +$21.1K +304 +2%
SM
5
Sabby Management
Florida
$520K +$558K +8,020 New
Renaissance Technologies
6
Renaissance Technologies
New York
$487K +$94.5K +1,359 +22%
Goldman Sachs
7
Goldman Sachs
New York
$486K +$254K +3,647 +95%
O
8
OrbiMed
New York
$453K -$441K -6,343 -48%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$198K +$8.34K +120 +4%
TC
10
TFS Capital
Pennsylvania
$184K -$531K -7,635 -73%
SKK
11
Shepherd Kaplan Krochuk
Massachusetts
$153K
CC
12
Cannell & Co
New York
$151K
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$121K
BFA
14
BlackRock Fund Advisors
California
$114K +$3.48K +50 +3%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$95K
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$54K -$37.6K -541 -39%
Northern Trust
17
Northern Trust
Illinois
$54K -$70 -1 -0.1%
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$49K
RCM
19
Rotella Capital Management
Washington
$48K -$23.2K -334 -31%
FAAS
20
First Allied Advisory Services
California
$43K
RA
21
Royce & Associates
New York
$43K
LTFS
22
Ladenburg Thalmann Financial Services
Florida
$37K
Nomura Holdings
23
Nomura Holdings
Japan
$30K
PAG
24
Private Advisor Group
New Jersey
$28K
Bank of New York Mellon
25
Bank of New York Mellon
New York
$26K +$139 +2 +0.5%